Meet ALPS

 

The world’s first transcatheter self-sustainable leadless pacemaker

incorporating a unique inertial energy harvesting technology synchronized with cardiac rhythm.

ALPS leadless pacemaker under x ray

ALPS – Rethinking Cardiac Rhythm Management

 

CAIRDAC has developed the only pacemaker incorporating a revolutionary energy harvesting module capable of powering the device with no energy limitation.

CAIRDAC brings disruptive technologies to conventional leadless pacemakers – meeting patients and healthcare professionals’ growing needs – with an all-in-one, cost-effective solution that will revolutionize patients’ quality of life.

ALPS is a unique, autonomous and endoscopically implanted leadless pacemaker incorporating a self-sustaining power patented technology harvesting the heart’s kinetic energy. 

Currently, CAIRDAC’s leadless pacemaker is in chronic preclinical testing phases with very consistent results in terms of compatibility and performance.

 

ALPS the leadless pacemaker hold in hand

We are very proud and inspired by the encouraging preliminary results of our preclinical tests. The device shows reliable energy performance. This technology is a key building-block for next generations of leadless pacemaker, and this will reshape the patient’s living conditions. CAIRDAC’s solution is in radical disruption with the way leadless pacemakers have been thought and conceptualized so far.”

An Nguyen-Dinh

CEO of CAIRDAC.

A Full Paradigm Shift in Cardiac Rhythm Management

Since the 60’s implantable pacemakers have been powered by a primary battery which needs to be replaced upon depletion; although leadless pacemakers have taken a big leap forward in the past few years, the same problem applies to leadless devices as their battery capacity is even more reduced due to miniaturization. Replacement or re-implantation of a new leadless device is a complicated procedure and an expensive solution for patients and healthcare systems.

Today, device longevity is the major weak point of current leadless pacemakers as they need to be replaced on average every 5 years becoming a complicated, risky and costly solution for patients and hospitals.

AND there is NO leadless solution for Dual Chamber Stimulation.

Patients and healthcare
professionals can now have it all

With ALPS’s innovative technology, the reality of dual-chamber stimulation and communication with a lifespan of over 15 years is here today, thus making it accessible for younger patients and compatible with healthcare systems cost effectiveness.

ALPS leadless pacemaker and heart

This patented technology allows for more unique
and never seen before capabilities such as :

Intercommunication between capsules once placed in the heart utilizing the latest Human Body Communication transmitter

 

Real-Time monitoring thanks to its holter which allows data to be collected, saved and shared.

ALPS’ miniature size enables it to be implanted endoscopically
which significantly reduces risks of infections and other complications.